busulfan has been researched along with Uveal Neoplasms in 12 studies
Uveal Neoplasms: Tumors or cancer of the UVEA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chemotherapy-naive patients with proven metastatic uveal melanoma were randomly assigned to receive 1000 mg/m(2) of gemcitabine plus 3500 mg/m(2) of treosulfan (GeT) or 3500 mg/m(2) of T." | 9.12 | A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma. ( Bechrakis, NE; Foerster, MH; Keilholz, U; Martus, P; Schmidt-Hieber, M; Schmittel, A; Schuster, R; Siehl, JM; Thiel, E, 2006) |
| "This trial was performed to define the maximum tolerated dose (MTD) of treosulfan administered in combination with a fixed dose of gemcitabine in uveal melanoma patients." | 9.11 | A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours. ( Bechrakis, N; Foerster, MH; Keilholz, U; Schmittel, A; Schuster, R; Siehl, J; Thiel, E, 2004) |
| "Gemcitabine plus treosulfan (GeT) is under investigation in metastatic uveal melanoma." | 9.11 | Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. ( Baumgart, J; Bechrakis, NE; Bornfeld, N; Foerster, MH; Keilholz, U; Scheulen, ME; Schmittel, A; Strumberg, D; Thiel, E, 2005) |
| "The efficacy of cisplatin, gemcitabine, and treosulfan (CGT) was evaluated in patients with chemotherapy pretreated relapsed AJCC stage IV uveal malignant melanoma." | 7.74 | Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients. ( Atzpodien, J; Fluck, M; Reitz, M; Terfloth, K, 2008) |
| "Uveal melanoma is relatively uncommon accounting for fewer than 5% of all melanoma cases." | 6.72 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. ( Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA, 2006) |
| "Chemotherapy-naive patients with proven metastatic uveal melanoma were randomly assigned to receive 1000 mg/m(2) of gemcitabine plus 3500 mg/m(2) of treosulfan (GeT) or 3500 mg/m(2) of T." | 5.12 | A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma. ( Bechrakis, NE; Foerster, MH; Keilholz, U; Martus, P; Schmidt-Hieber, M; Schmittel, A; Schuster, R; Siehl, JM; Thiel, E, 2006) |
| "Results from in vitro chemosensitivity testing recommend treosulfan/gemcitabine chemotherapy for the treatment of stage IV uveal melanoma." | 5.11 | Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma. ( Becker, JC; Bröcker, EB; Terheyden, P, 2004) |
| "This trial was performed to define the maximum tolerated dose (MTD) of treosulfan administered in combination with a fixed dose of gemcitabine in uveal melanoma patients." | 5.11 | A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours. ( Bechrakis, N; Foerster, MH; Keilholz, U; Schmittel, A; Schuster, R; Siehl, J; Thiel, E, 2004) |
| "Gemcitabine plus treosulfan (GeT) is under investigation in metastatic uveal melanoma." | 5.11 | Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. ( Baumgart, J; Bechrakis, NE; Bornfeld, N; Foerster, MH; Keilholz, U; Scheulen, ME; Schmittel, A; Strumberg, D; Thiel, E, 2005) |
| "The efficacy of cisplatin, gemcitabine, and treosulfan (CGT) was evaluated in patients with chemotherapy pretreated relapsed AJCC stage IV uveal malignant melanoma." | 3.74 | Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients. ( Atzpodien, J; Fluck, M; Reitz, M; Terfloth, K, 2008) |
| "In this study we have used a standardised ATP-based tumour chemosensitivity assay (ATP-TCA) to measure the activity of gefitinib alone or in combination with different cytotoxic drugs (cisplatin, gemcitabine, oxaliplatin and treosulfan) against a variety of solid tumours (n = 86), including breast, colorectal, oesophageal and ovarian cancer, carcinoma of unknown primary site, cutaneous and uveal melanoma, non-small cell lung cancer (NSCLC) and sarcoma." | 3.72 | The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. ( Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P, 2004) |
| "Uveal melanoma is relatively uncommon accounting for fewer than 5% of all melanoma cases." | 2.72 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. ( Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (91.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saakyan, SV | 1 |
| Tsygankov, АY | 1 |
| Moiseeva, NI | 1 |
| Karamysheva, АF | 1 |
| Garri, DD | 1 |
| Pföhler, C | 1 |
| Cree, IA | 4 |
| Ugurel, S | 1 |
| Kuwert, C | 1 |
| Haass, N | 1 |
| Neuber, K | 1 |
| Hengge, U | 1 |
| Corrie, PG | 2 |
| Zutt, M | 1 |
| Tilgen, W | 1 |
| Reinhold, U | 2 |
| Terheyden, P | 1 |
| Bröcker, EB | 1 |
| Becker, JC | 1 |
| Keilholz, U | 4 |
| Schuster, R | 3 |
| Schmittel, A | 4 |
| Bechrakis, N | 1 |
| Siehl, J | 1 |
| Foerster, MH | 4 |
| Thiel, E | 4 |
| Knight, LA | 1 |
| Di Nicolantonio, F | 1 |
| Whitehouse, P | 1 |
| Mercer, S | 1 |
| Sharma, S | 1 |
| Glaysher, S | 1 |
| Johnson, P | 1 |
| Neale, MH | 1 |
| Kurbacher, CM | 1 |
| Shaw, J | 1 |
| Spanswick, VJ | 1 |
| Sehmbi, R | 1 |
| Jonson, A | 1 |
| Mayer, A | 1 |
| Bulusu, R | 1 |
| Hartley, JA | 1 |
| Scheulen, ME | 1 |
| Bechrakis, NE | 3 |
| Strumberg, D | 1 |
| Baumgart, J | 1 |
| Bornfeld, N | 1 |
| Siehl, JM | 2 |
| O'Neill, PA | 1 |
| Butt, M | 1 |
| Eswar, CV | 1 |
| Gillis, P | 1 |
| Marshall, E | 1 |
| Schmidt-Hieber, M | 1 |
| Martus, P | 1 |
| Atzpodien, J | 1 |
| Terfloth, K | 1 |
| Fluck, M | 1 |
| Reitz, M | 1 |
8 trials available for busulfan and Uveal Neoplasms
| Article | Year |
|---|---|
Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Ch | 2003 |
Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols | 2004 |
A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Deoxycytidine; Female; Gemcit | 2004 |
Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Comet Assay; Deoxycytidine; D | 2005 |
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Topics: Adult; Aged; Anemia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplas | 2005 |
A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cohort Studies; Deoxycytidine | 2005 |
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Humans; | 2006 |
A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Deoxycytid | 2006 |
4 other studies available for busulfan and Uveal Neoplasms
| Article | Year |
|---|---|
Assessment of the Chemosensitivity of Uveal Melanoma Cells Ex Vivo.
Topics: Adult; Aged; Antineoplastic Agents; Benzeneacetamides; Busulfan; Cell Proliferation; Cell Survival; | 2020 |
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 2004 |
Treosulfan and gemcitabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Deoxycytidine; Gemcitabine; Humans; Melano | 2005 |
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Fem | 2008 |